Blood · 1979 · 133 citations · 30 references
MedicineHematologyHemostasisPlatelet ActivationPlatelet AggregationPlatelet DisordersPlatelet FunctionPlatelet PhysiologyThrombosisFibrin-platelet InteractionsFibrinogen BindingFibrinogen InfluenceFibrinogen InteractionThrombogenicity
Although 125I-fibrinogen becomes associated with washed platelets from normal human subjects during ADP-induced shape change and aggregation, 125I-fibrinogen did not become associated with washed plateletes from a thrombasthenic subject during ADP-induced shape change and the platelets did not aggregate. Platelets from control and thrombasthenic subjects were treated with chymotrypsin, which is known to degrade platelet membrane glycoproteins. More 125I-fibrinogen became associated with chymotrypsin-pretreated platelets from normal subejcts than with untreated platelets, and fibrinogen caused the enzyme-treated platelets to aggregate. 125I-fibrinogen did not become associated with chymotrypsin-pretreated thromobasthenic platelets, and fibrinogen did not aggregate them. Thus, there appears to be a defect in thrombasthenic platelets that prevents the association of fibrinogen with them.
30
Efficient Trace-labelling of Proteins with Iodine
A. S. McFarlane · Nature · 1958 · 2.6K citations
Preparation of Suspensions of Washed Platelets from Humans
J. F. Mustard, Dennis Perry, N.G. Ardlie et al. · British Journal of Haematology · 1972 · 840 citations
Medicine, Cell Biology, Hematology +16